ReviewCureus2026
Artificial Intelligence and Clinician Burnout in the United States: A Narrative Review.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Burnout remains one of the defining occupational hazards of healthcare in the United States, and it spares no one on the care team: physicians, nurses, trainees, and assistants all report it at high rates. When generative AI entered healthcare around 2023, it arrived quickly and carried a promise of relief from the administrative burden that so many clinicians identify as a reason for their exhaustion. This review asks one question about that promise: Does the current evidence from the United States indicate that AI alleviates or worsens clinician burnout, and under what implementation conditions? We approached this question through a structured thematic narrative synthesis, weighting evidence by study design. Randomized controlled trials carried the greatest interpretive weight, while non-randomized studies were considered lower-certainty supporting evidence. The first randomized trials of AI-assisted scribing, published in 2025-2026, are encouraging with respect to documentation time and, in some trials, well-being. Yet most of what has been published so far is non-randomized, single-center, and short-term. The more troubling pattern is that AI tends to displace work rather than reduce it. Tasks are not eliminated but moved: from production to oversight, and potentially from physicians to nurses and assistants. Where earlier commentaries offered the metaphors of a "double-edged scalpel" and a "productivity paradox," this review proposes "displacement of burden" as a framework that can actually be tested.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.